Pharmacogenomics News: Breaking Pharmacogenomics News, Comments and Articles.

Caligor Rx Managing Director Tammy Bishop Elected to Board of Directors for Diversity Alliance for Science

Caligor Rx, a leader in the global procurement of comparator drugs for clinical trials worldwide, today announced that Managing Director Tammy Bishop has been elected to the Board of Directors for Diversity Alliance for Science (DA4S), a national organization that fosters supplier diversity within the life sciences industry. Tammy Bishop, managing dir...

Celerion Appoints Dr. Bruce Morimoto as Executive Director, Applied Translational Medicine

Celerion is pleased to announce the appointment of Dr. Bruce Morimoto as Executive Director of Applied Translational Medicine. Dr. Morimoto will have responsibility for developing and implementing strategies for patient populations in early clinical research and clinical pharmacology studies. Dr. Morimoto will also assume leadership for the External...

The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research

ALBANY, New York, May 21, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Biochip Products and Services Market (Microarrays, Reagents, Drug Discovery, Life Science Research, IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the market was valu...

Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets

BALTIMORE, May 21, 2013 /PRNewswire/ -- Personal Genome Diagnostics Inc. (PGDx), today announced that it will use its proprietary methodologies and expertise in genomic analysis of defined cancer subtypes to identify novel kinase targets in collaboration with Blueprint Medicines.  PGDx is an innovator in conducting patient-specific analyses aimed at identifying genomic alterations in tum...

Michael Wayne Korth, DDS, PC Recognized by Strathmore's Who's Who Worldwide Publication

Houston, TX, May 21, 2013 --(PR.com)-- Michael Wayne Korth, DDS, PC, of Houston, Texas has been included in the Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and achievements in the field of healthcare. About Michael Wayne Korth, DDS, PC Dr. Korth has over 20 years experience in the field of dental care. He is a Periodontist at Michael W. Korth, DDS, PC i...

Inside job: ligand-receptor pharmacology beneath the plasma membrane

Injectable drug error project wins UKCPA grant

A project to investigate errors and near misses in the preparation of injectable medicines within pharmacy departments has won the 2013 UK Clinical Pharmacy Association clinical pharmacy research grant. Lynette James, lecturer in pharmacy practic...

Record-Breaking: The 4-Day Pandemic Flu Vaccine

A team of researchers for the J. Craig Venter Institute (JCVI), Synthetic Genomics Inc (SGI), Novartis Vaccines and Diagnostics, the Biomedical Advanced Research and Development [...]

Authors urge importance of patients’ rights in genome sequencing

Upcoming paper in ‘Science’ pushes back against recent recommendations from the American College of Medical Genetics and Genomics. (News-medical)

BRIEF-Rosetta Genomics up 11.8 percent in premarket trade

NEW YORK, May 20 (Reuters) - Rosetta Genomics Ltd : * Up 11.8 percent to $3.80 in premarket trade

New Study Identifies the Optimal Dose of Intravenous Vitamin C for Future Anticancer Clinical Trials

SCHAUMBURG, Ill., May 20, 2013 /PRNewswire-USNewswire/ -- The use of vitamin C to treat cancer patients first became popular in the 1970s as a result of the work of Nobel Laureate Linus Pauling.  However, studies conducted with orally dosed supplements did not demonstrate any clinical benefit in cancer patients, most likely due to the finding that the levels of orally-administered vitamin C d...

Nebulized Arformoterol: Its Place in the Management of COPD

Find out about the pharmacology and safety of arformoterol in patients with COPD. Therapeutic Advances in Respiratory Disease

Cancer, genomics and technological solutionism: A time to be wary

[caption id="attachment_1465" align="alignleft" width="300" caption="Genetic sequencing may provide easy data but the truly useful missing data might lie at the level of protein signaling pathways (Image: Yaffe, Science Signaling, 2013, doi: 10.1126/...

Rosetta Genomics Announces Credentialing Agreement with Prime Health Services for miRview mets2

PHILADELPHIA and REHOVOT, Israel, May 20, 2013 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that the Company has executed a credentialing agreement with Prime Health Services, Inc. (Prime Health), a managed care company that offers a full spectrum of services, including a Preferred...

Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer

WOBURN, Mass., May 20, 2013 /PRNewswire/ -- Flexion Therapeutics, Inc. today announced the addition of Frederick W. Driscoll to its management team as chief financial officer. Mr. Driscoll has more than 30 years of financial management experience with biotechnology and medical device companies. Prior to joining Flexion, Mr. Driscoll was chief financial officer for Novavax (NASDAQ: NVAX) wher...

AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy

NORTH CHICAGO, Ill., May 20, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease (CKD) and...

Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells

Recent molecular studies have shown that, even when derived from a seemingly homogenous population, individual cells can exhibit substantial differences in gene expression, protein levels and phenotypic output, with important functional consequences....

UK-Norwegian Collaboration Aims to Develop a New Living Skin Equivalent Testing Model for Testing Inflammatory Responses

MANCHESTER, UNITED KINGDOM -- (Marketwired) -- 05/20/13 -- Epistem (LSE: EHP), the UK biotechnology and personalized medicine company with expertise in skin biology and delivery of dermatological testing services, and ScandiDerma, a Norwegian company with expertise in developing new dermatological ingredients from biomass, today announced that they aim to develop a new in vitro human living skin...

Elsevier, Illumina collaborate to launch Genomics Data app

Elsevier has collaborated with Illumina to launch Genomics Data app, a sequencing and array-based solutions provider for genetics research.

Reporting Incidental Findings In Gene Sequencing: Ethicists Provide Framework Supporting New Recommendations

In a paper published in Science Express, a group of experts led by bioethicists in the Center for Medical Ethics and Health Policy at Baylor College of Medicine provide a framework for the new American College of Medical Genetics and Genomics (ACMG)...

Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com

Molecular Diagnostics Market research reports for US, UK, Spain, Japan, Italy, Germany and France are added to ReportsnReports.com stores. Dalla, TX (PRWEB) May 19, 2013 These molecular diagnostics market reports provide a comprehensive analysis for US, UK, Spain, Japan, Italy, Germany and France:     Major issues pertaining to the molecular diagnostics laboratory practice, a...

RUCDR Infinite Biologics creates new Genomics Technology Center

RUCDR Infinite Biologics, the world's largest university-based biorepository, has completed an $11.8 million renovation project to create a new Genomics Technology Center, comprising 12,500 square feet of laboratory, office, and storage space on the...

Authors urge importance of patients' rights in genome sequencing

Informed consent is the backbone of patient care. Genetic testing has long required patient consent and patients have had a "right not to know" the results. However, as 21st century medicine now begins to use the tools of genome sequencing, an enormo...

Additional macitentan (Opsumit) data in pulmonary arterial hypertension presented at ATS

Actelion Pharmaceuticals Ltd / Additional macitentan (Opsumit) data in pulmonary arterial hypertension presented at ATS . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. ALLSCHWIL/BASEL, SWITZERLAND - 17 May 2013 - Actelion (SIX: ATLN) today announced that further data for its investigational drug macitentan (Opsumit®) wil...

Computational Analysis in Clinical and Preclinical Decision-Making, new webinar hosted by Xtalks

Xtalks presents an exciting live webinar on Wednesday May 29, 2013 at 11:00am EDT on applying computational analysis of complex genomics data sets to clinical and preclinical decision-making. Toronto, Canada (PRWEB) May 17, 2013 The paradigm of ‘one drug, one target’ has evolved to understanding complex biological systems that can help predict the adverse and therapeutic effects of a drug. Ke...